NASDAQ · ADXN
Addex Therapeutics Ltd.
Follow ADXN
Get an email when an officer or director makes an open-market buy or sale of ADXN. Free. Routine grants and planned sales are left out.
Smart money pulse
What insiders and funds are doing
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
−100 means everyone selling, +100 everyone buying. This is data, not advice.
How the Pulse works
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.
Who owns it
2 funds report owning ADXN, down from 4
Insider trades · last 12 months
Real buys and sales
No open-market buys or sales by officers or directors in the last 12 months. Hidden: 7 stock grants. Press All filings to see them.
Last 6 months. A wider screen shows 12.
Showing 0 real trades. Hidden: 7 stock grants. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.
Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.
Top holders
Biggest funds in ADXN
| Fund | Value | Change |
|---|---|---|
| UBS Group AG | $268 | New |
| SBI Securities Co., Ltd. | $6 | Same |
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.